From: A novel immunohistochemical score predicts the postoperative prognosis of gastric cancer patients
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
P | HR | 95% confidence interval | P | HR | 95% confidence interval | |
Gender Male/female | 0.921 | 1.020 | 0.692–1.504 | |||
Age > 60 years/ ≤ 60 years | 0.181 | 0.817 | 0.608–1.099 | |||
ASA II/I | 0.714 | 0.920 | 0.587–1.440 | |||
ECOG PS 1/0 | 0.984 | 1.004 | 0.706–1.427 | |||
TNM stage | < 0.001 | 1.711 | 1.490–1.965 | < 0.001 | 1.584 | 1.365–1.837 |
Tumor size | 0.002 | 1.594 | 1.182–2.149 | 0.119 | 1.283 | 0.938–1.755 |
> 5.0 cm/ ≤ 5.0 cm | ||||||
Vascular invasion | 0.427 | 1.131 | 0.835–1.531 | |||
Yes/No | ||||||
P53 | < 0.001 | 2.298 | 1.682–3.140 | 0.005 | 1.862 | 1.205–2.880 |
± | ||||||
Ki-67 ≥ / < | < 0.001 | 2.614 | 1.923–3.555 | 0.027 | 1.606 | 1.055–2.444 |
MSI status MSI-high/MSS or MSI-low | < 0.001 | 2.710 | 1.880–3.907 | < 0.001 | 2.771 | 1.864–4.121 |